{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:15:40Z","timestamp":1785147340043,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1053\/j.ajkd.2017.06.020","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T14:30:12Z","timestamp":1502721012000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Marijuana and Cannabinoids in ESRD and Earlier Stages\u00a0of CKD"],"prefix":"10.1053","volume":"71","author":[{"given":"Joshua L.","family":"Rein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 suppl 1","key":"10.1053\/j.ajkd.2017.06.020_bib1","first-page":"S1","article-title":"US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States","volume":"66","author":"Saran","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1152\/physrev.00002.2016","article-title":"From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology","volume":"96","author":"Ligresti","year":"2016","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.020_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/jbcpp-2015-0055","article-title":"The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases","volume":"27","author":"Tam","year":"2016","journal-title":"J\u00a0Basic Clin Physiol Pharmacol"},{"issue":"50","key":"10.1053\/j.ajkd.2017.06.020_bib5","doi-asserted-by":"crossref","first-page":"E5420","DOI":"10.1073\/pnas.1419901111","article-title":"Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy","volume":"111","author":"Jourdan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/db09-1336","article-title":"Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy","volume":"59","author":"Barutta","year":"2010","journal-title":"Diabetes"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.020_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2015.63","article-title":"Cannabinoid receptor 1 is a major mediator of renal fibrosis","volume":"88","author":"Lecru","year":"2015","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2017.06.020_bib8","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db10-1809","article-title":"Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy","volume":"60","author":"Barutta","year":"2011","journal-title":"Diabetes"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.020_bib9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ki.2014.165","article-title":"Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice","volume":"86","author":"Barutta","year":"2014","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.020_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.112.199331","article-title":"Diuretic effects of cannabinoids","volume":"344","author":"Paronis","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib11","doi-asserted-by":"crossref","first-page":"F376","DOI":"10.1152\/ajprenal.00239.2012","article-title":"Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors","volume":"304","author":"Silva","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.020_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2015.10.019","article-title":"Metabolic syndrome among marijuana users in the United States: an analysis of National Health and Nutrition Examination Survey data","volume":"129","author":"Vidot","year":"2016","journal-title":"Am J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2017.06.020_bib13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1017\/S0033291715002883","article-title":"Metabolic syndrome in people with a psychotic illness: is cannabis protective?","volume":"46","author":"Waterreus","year":"2016","journal-title":"Psychol Med"},{"key":"10.1053\/j.ajkd.2017.06.020_bib14","doi-asserted-by":"crossref","first-page":"e000494","DOI":"10.1136\/bmjopen-2011-000494","article-title":"Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III","volume":"2","author":"Rajavashisth","year":"2012","journal-title":"BMJ Open"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.ajkd.2003.12.027","article-title":"The risk for mild kidney function decline associated with illicit drug use among hypertensive men","volume":"43","author":"Vupputuri","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0376-8716(85)90054-7","article-title":"Drug addicts and renal lesions","volume":"16","author":"Sommer","year":"1985","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.020_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ajkd.2016.06.028","article-title":"Hypophosphatemia in users of cannabis","volume":"69","author":"Cadman","year":"2017","journal-title":"Am J\u00a0Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","article-title":"Synthetic pot: not your grandfather's marijuana","volume":"38","author":"Ford","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2215\/CJN.05690612","article-title":"AKI associated with synthetic cannabinoids: a case series","volume":"8","author":"Bhanushali","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib20","first-page":"93","article-title":"Acute kidney injury associated with synthetic cannabinoid use\u2013multiple states, 2012","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.020_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/15563650.2014.932365","article-title":"Acute kidney injury associated with smoking synthetic cannabinoid","volume":"52","author":"Buser","year":"2014","journal-title":"Clin Toxicol"},{"issue":"11","key":"10.1053\/j.ajkd.2017.06.020_bib22","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.2215\/CJN.00360114","article-title":"Nephrotoxic effects of common and emerging drugs of abuse","volume":"9","author":"Pendergraft","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrneph.2014.44","article-title":"Nephrotoxic effects of designer drugs: synthetic is not better!","volume":"10","author":"Luciano","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.020_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.ackd.2016.09.008","article-title":"Tubulointerstitial injury and drugs of abuse","volume":"24","author":"Nanavati","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jpainsymman.2010.06.016","article-title":"Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?","volume":"41","author":"Davison","year":"2011","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"1","key":"10.1053\/j.ajkd.2017.06.020_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.020_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02791072.2015.1096433","article-title":"Self-medication of somatic and psychiatric conditions using botanical marijuana","volume":"47","author":"Osborn","year":"2015","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1053\/j.ajkd.2017.06.020_bib28","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"10.1053\/j.ajkd.2017.06.020_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fphar.2016.00355","article-title":"Splendor in the grass? A pilot study assessing the impact of medical marijuana on executive function","volume":"7","author":"Gruber","year":"2016","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.020_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa1000552","article-title":"A\u00a0randomized, controlled trial of early versus late initiation of dialysis","volume":"363","author":"Cooper","year":"2010","journal-title":"N\u00a0Engl J\u00a0Med"},{"issue":"5","key":"10.1053\/j.ajkd.2017.06.020_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.ajkd.2010.12.018","article-title":"Cost-effectiveness of initiating dialysis early: a randomized controlled trial","volume":"57","author":"Harris","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.ajkd.2016.08.039","article-title":"Pain management in CKD: a guide for nephrology providers","volume":"69","author":"Koncicki","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.20713","article-title":"Uremic neuropathy: clinical features and new pathophysiological insights","volume":"35","author":"Krishnan","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1053\/j.ajkd.2017.06.020_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.drugalcdep.2017.01.006","article-title":"Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever","volume":"173","author":"Shi","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1053\/j.ajkd.2017.06.020_bib35","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tins.2016.12.006","article-title":"Cannabidiol: swinging the marijuana pendulum from \u2018weed\u2019 to medication to treat the opioid epidemic","volume":"40","author":"Hurd","year":"2017","journal-title":"Trends Neurosci"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000013336","article-title":"Timing of initiation of uremia therapy and survival in patients with progressive renal disease","volume":"18","author":"Ifudu","year":"1998","journal-title":"Am J Nephrol"},{"issue":"16","key":"10.1053\/j.ajkd.2017.06.020_bib38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"Sallan","year":"1975","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2017.06.020_bib39","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ki.2013.147","article-title":"Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism","volume":"84","author":"Ikizler","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.semnephrol.2015.06.009","article-title":"Pruritus in kidney disease","volume":"35","author":"Combs","year":"2015","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00213-011-2224-5","article-title":"CB1 receptors mediate Rimonabant-induced pruritic responses in mice: investigation of locus of action","volume":"216","author":"Schlosburg","year":"2011","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1774-9987.2005.00271.x","article-title":"Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options","volume":"9","author":"Szepietowski","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.ajkd.2017.06.020_bib44","unstructured":"Suitability for Organ Transplant, Medical Cannabis, RCW 69.51A.110, 2011 c 181 \u00a7 408. http:\/\/app.leg.wa.gov\/rcw\/default.aspx?cite=69.51A.110. Accessed April 20,\u00a02017."},{"issue":"10","key":"10.1053\/j.ajkd.2017.06.020_bib45","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/ctr.12828","article-title":"Recreational marijuana use is not associated with worse outcomes after renal transplantation","volume":"30","author":"Greenan","year":"2016","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00498259609046707","article-title":"Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes","volume":"26","author":"Jaeger","year":"1996","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1189\/jlb.3A0115-030RR","article-title":"\u0394\u2079-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of\u00a0myeloid-derived suppressor cells","volume":"98","author":"Sido","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1053\/j.ajkd.2017.06.020_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnmol.2017.00014","article-title":"Modulation of human peripheral blood mononuclear cell signaling by medicinal cannabinoids","volume":"10","author":"Utomo","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"10.1053\/j.ajkd.2017.06.020_bib49","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/00007890-199606270-00018","article-title":"Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient","volume":"61","author":"Marks","year":"1996","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib50","first-page":"338","article-title":"Exogenous lipid pneumonia related to smoking weed oil following cadaveric renal transplantation","volume":"7","author":"Vethanayagam","year":"2000","journal-title":"Can Respir J"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.020_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ajkd.2011.03.025","article-title":"Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity","volume":"58","author":"Liebman","year":"2011","journal-title":"Am J\u00a0Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib52","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1165\/ajrcmb.20.6.3424","article-title":"Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids","volume":"20","author":"Sarafian","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1053\/j.ajkd.2017.06.020_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1513\/AnnalsATS.201212-127FR","article-title":"Effects of marijuana smoking on the lung","volume":"10","author":"Tashkin","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.020_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2011.1961","article-title":"Association between marijuana exposure and pulmonary function over 20 years","volume":"307","author":"Pletcher","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.ajkd.2017.06.020_bib55","doi-asserted-by":"crossref","first-page":"e003858","DOI":"10.1161\/JAHA.116.003858","article-title":"One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function","volume":"5","author":"Wang","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1053\/j.ajkd.2017.06.020_bib56","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/HJH.0000000000000990","article-title":"Cannabis use and blood pressure levels: United States National Health and Nutrition Examination\u00a0Survey, 2005-2012","volume":"34","author":"Alshaarawy","year":"2016","journal-title":"J\u00a0Hypertens"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib57","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s11255-012-0153-9","article-title":"Role of arachidonoylethanolamine in blood pressure regulation in volume-resistant patients on peritoneal dialysis","volume":"44","author":"Bai","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2017.06.020_bib58","doi-asserted-by":"crossref","first-page":"e000638","DOI":"10.1161\/JAHA.113.000638","article-title":"French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders","volume":"3","author":"Jouanjus","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1053\/j.ajkd.2017.06.020_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jns.2016.01.066","article-title":"Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States","volume":"364","author":"Rumalla","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"23","key":"10.1053\/j.ajkd.2017.06.020_bib60","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.103.23.2805","article-title":"Triggering myocardial infarction by marijuana","volume":"103","author":"Mittleman","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/cid\/cix391","article-title":"Marijuana use impacts midlife cardiovascular events in HIV-infected men","volume":"65","author":"Lorenz","year":"2017","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1053\/j.ajkd.2017.06.020_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2105\/AJPH.2017.303654","article-title":"Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"107","author":"Reis","year":"2017","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.020_bib63","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamapsychiatry.2016.0637","article-title":"Associations between cannabis use and physical health problems in early midlife: a longitudinal comparison of persistent cannabis vs tobacco users","volume":"73","author":"Meier","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib64","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.ajkd.2016.11.015","article-title":"Cognitive decline and its risk factors in prevalent hemodialysis patients","volume":"69","author":"Drew","year":"2017","journal-title":"Am J\u00a0Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2015.12.028","article-title":"Cognition in people with\u00a0end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis","volume":"67","author":"O'Lone","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2017.06.020_bib66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and chronic effects of cannabinoids on human cognition-a systematic review","volume":"79","author":"Broyd","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1053\/j.ajkd.2017.06.020_bib67","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nm.4311","article-title":"A\u00a0chronic low dose of \u03949-tetrahydrocannabinol (THC) restores cognitive function in old mice","volume":"23","author":"Bilkei-Gorzo","year":"2017","journal-title":"Nat Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638617308107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:09:19Z","timestamp":1759460959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638617308107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0272638617308107"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.06.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Marijuana and Cannabinoids in ESRD and Earlier Stages\u00a0of CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2017.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}